Catalyst Wire Dossier Catalyst Wire Dossier

Iron isomaltoside/ferric derisomaltose

ferric derisomaltose · Pharmacosmos A/S
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for Iron isomaltoside/ferric derisomaltose, covering 2020-02-25 to 2020-03-06. Get the full timeline:

Most recent: Clinical Trial Update: Iron Isomaltoside/Ferric Derisomaltose vs Iron Sucrose for Treatment of Iron Deficiency Anemia in Non-Dialysis-Dependent Chronic Kidney Disease [Phase 3]

See pricing